Fluidigm Co. (FLDM) Insider Buys $78,600.00 in Stock

Fluidigm Co. (NASDAQ:FLDM) insider Levin Capital Strategies, L.P. purchased 10,000 shares of the business’s stock in a transaction dated Thursday, February 15th. The shares were acquired at an average price of $7.86 per share, with a total value of $78,600.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Levin Capital Strategies, L.P. also recently made the following trade(s):

  • On Wednesday, February 7th, Levin Capital Strategies, L.P. purchased 53,610 shares of Fluidigm stock. The shares were acquired at an average price of $5.73 per share, with a total value of $307,185.30.
  • On Monday, February 5th, Levin Capital Strategies, L.P. purchased 50,987 shares of Fluidigm stock. The shares were acquired at an average price of $5.96 per share, with a total value of $303,882.52.
  • On Thursday, February 1st, Levin Capital Strategies, L.P. purchased 152,891 shares of Fluidigm stock. The shares were acquired at an average price of $6.18 per share, with a total value of $944,866.38.
  • On Tuesday, January 23rd, Levin Capital Strategies, L.P. purchased 6,871 shares of Fluidigm stock. The shares were acquired at an average price of $6.57 per share, with a total value of $45,142.47.
  • On Tuesday, January 16th, Levin Capital Strategies, L.P. purchased 887 shares of Fluidigm stock. The shares were acquired at an average price of $6.68 per share, with a total value of $5,925.16.
  • On Wednesday, January 10th, Levin Capital Strategies, L.P. purchased 100,576 shares of Fluidigm stock. The shares were acquired at an average price of $6.34 per share, with a total value of $637,651.84.
  • On Wednesday, January 3rd, Levin Capital Strategies, L.P. purchased 29 shares of Fluidigm stock. The shares were acquired at an average price of $6.63 per share, with a total value of $192.27.
  • On Thursday, December 28th, Levin Capital Strategies, L.P. purchased 30 shares of Fluidigm stock. The shares were acquired at an average price of $5.82 per share, with a total value of $174.60.
  • On Friday, December 29th, Levin Capital Strategies, L.P. purchased 11,230 shares of Fluidigm stock. The shares were acquired at an average price of $5.94 per share, with a total value of $66,706.20.
  • On Wednesday, December 27th, Levin Capital Strategies, L.P. purchased 27,100 shares of Fluidigm stock. The shares were acquired at an average price of $5.88 per share, with a total value of $159,348.00.

Fluidigm Co. (FLDM) opened at $7.81 on Wednesday. The company has a debt-to-equity ratio of 5.00, a quick ratio of 2.46 and a current ratio of 3.02. Fluidigm Co. has a 12 month low of $2.52 and a 12 month high of $8.38.

Fluidigm (NASDAQ:FLDM) last issued its earnings results on Thursday, February 8th. The medical research company reported ($0.27) EPS for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.02). The firm had revenue of $27.75 million during the quarter, compared to analyst estimates of $27.14 million. Fluidigm had a negative net margin of 59.38% and a negative return on equity of 116.02%. The business’s revenue for the quarter was up 10.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.32) earnings per share. equities analysts anticipate that Fluidigm Co. will post -0.93 EPS for the current fiscal year.

A number of research analysts have recently commented on FLDM shares. ValuEngine lowered Fluidigm from a “sell” rating to a “strong sell” rating in a report on Thursday, November 9th. BidaskClub upgraded Fluidigm from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, February 13th. Finally, Piper Jaffray Companies restated a “hold” rating and issued a $6.10 target price on shares of Fluidigm in a research note on Thursday, February 8th.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Paloma Partners Management Co acquired a new position in shares of Fluidigm in the fourth quarter valued at $100,000. Virtu KCG Holdings LLC acquired a new position in shares of Fluidigm in the second quarter valued at $105,000. Sei Investments Co. raised its stake in shares of Fluidigm by 221.7% in the third quarter. Sei Investments Co. now owns 21,668 shares of the medical research company’s stock valued at $109,000 after purchasing an additional 14,932 shares in the last quarter. Group One Trading L.P. raised its stake in shares of Fluidigm by 336.9% in the third quarter. Group One Trading L.P. now owns 23,155 shares of the medical research company’s stock valued at $117,000 after purchasing an additional 17,855 shares in the last quarter. Finally, MetLife Investment Advisors LLC acquired a new position in shares of Fluidigm in the fourth quarter valued at $121,000. Institutional investors and hedge funds own 97.61% of the company’s stock.

WARNING: “Fluidigm Co. (FLDM) Insider Buys $78,600.00 in Stock” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://www.dispatchtribunal.com/2018/02/21/fluidigm-co-fldm-insider-buys-78600-00-in-stock.html.

Fluidigm Company Profile

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Insider Buying and Selling by Quarter for Fluidigm (NASDAQ:FLDM)

Receive News & Ratings for Fluidigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply